Quaternary-ammonium disinfectants, which are widely used in US hospitals, were less effective.
One study finds a significant increase in C auris bloodstream infections in US hospitals.
Rise of the multidrug-resistant fungal pathogen was driven primarily by COVID-19 surges and mechanical ventilation, the authors say.
CDC researchers review 192 C auris–associated hospitalizations, including 38 C auris bloodstream infections (20%), and note a crude mortality rate of 34%.
Data collected from 88 Canadian hospitals from January 2017 through December 2021 show that rates of MRSA bloodstream infections rose 35%.
Risk factors include receiving intubation, a central venous line, or a drain, plus receipt of antifungal drugs within 7 days of admission.
Analysis of wastewater isolates revealed phylogenetic relatedness to isolates from three acute-care hospitals in the same watershed.
Despite limited data, new WHO report highlights 19 fungi that represent the greatest threat to public health.
The European Centre for Disease Prevention and Control (ECDC) yesterday issued a warning about an ongoing outbreak of the multidrug-resistant yeast Candida auris in Italy.
A randomized clinical trial found that fosfomycin did not demonstrate noninferiority to comparator antibiotics for bacteremic urinary tract infections (bUTIs) caused by multidrug-resistant (MDR) Escherichia coli, but it could remain an option for select patients, researchers reported yesterday in JAMA Network Open.
